cefoperazone has been researched along with piperacillin in 104 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 45 (43.27) | 18.7374 |
1990's | 15 (14.42) | 18.2507 |
2000's | 17 (16.35) | 29.6817 |
2010's | 23 (22.12) | 24.3611 |
2020's | 4 (3.85) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Ayala, JA; Casellas, JM; Di Conza, J; Ghiglione, B; Gutkind, G; Power, P; Radice, M; Rodríguez, MM | 1 |
Kwon, DH; Lu, CD | 1 |
Hsiao, YJ; Hu, RM; Huang, KJ; Wu, LT; Yang, TC | 1 |
Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
Cai, JC; Chen, GX; Zhang, R; Zhou, HW | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J | 1 |
Ichiishi, S; Mikamo, H; Nakao, K; Shibata, T; Tanaka, K; Watanabe, K | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH | 1 |
Bai, N; Cai, Y; Li, R; Liang, B; Liu, Y; Wang, R | 1 |
Collins, B; Cotter, PD; Curtis, N; Hill, C; Ross, RP | 1 |
Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Aoki, I; Kikuchi, M; Torii, Y; Toyama, K; Wakasugi, K | 1 |
Acar, JF; Denis, F; Drugeon, H; Fleurette, J; Kazmierczak, A; Siebor, E; Sirot, J; Soussy, CJ; Thabaut, A | 1 |
Bruckner, DA; Champlin, RE; Ho, WG; Winston, DJ | 1 |
Anderson, PH; Barry, AL; Fuchs, PC; Shilling, S; Stickel, S | 1 |
Kobayashi, J; Kouda, M; Kumagai, I; Matsuzaki, H; Sugai, R | 1 |
Sanders, CC; Sanders, WE; Thomson, KS; Weber, DA | 1 |
Bruckner, DA; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ | 1 |
Cesari, C; Cimino, M; Fenner, J; Rotstein, C; Winkey, K | 1 |
Bodey, GP; Elting, L; Ho, DH | 1 |
Blacklock, H; Corringham, R; Devereux, S; Guimaraes, M; Hann, I; Hoffbrand, AV; Prentice, HG; Sage, R; Stirling, L; Trikka, E | 1 |
Bale, M; Howard, W; Koontz, F; Pfaller, M; Preston, T | 1 |
Donato, JB; Joseph, WS; LeFrock, JL; McCloskey, RV; Smith, BR; Weber, SJ | 1 |
Belobraydic, KA; Flournoy, DJ; Qadri, SM | 1 |
Alivisatos, MR; Bollinger, MR; Greenberg, RN | 1 |
Henry, DA; Jones, MA; Smith, JA | 1 |
Barza, M; Giuliano, M; Gorbach, SL; Jacobus, NV | 3 |
Saikawa, I | 1 |
Fujiwara, H; Harada, S; Hidaka, K; Hisatsugu, T; Katano, M; Kisu, T; Mizoguchi, T; Yamamoto, H; Yamaoka, K | 1 |
Arione, R; Di Nola, F; Marietti, G | 1 |
Jehl, F; Monteil, H | 1 |
Doty, JE; Manchester, B; Mann, LL; Muller, EL; Pitt, HA; Thompson, JE | 1 |
Howell, AW; Jorgensen, JH; Redding, JS | 1 |
Chin, NX; Labthavikul, P; Neu, HC; Saha, G | 1 |
Cowles, LS; Johnson, JD; Raff, MJ; Reid, KH; Shields, CB | 1 |
Hayashi, T; Kitayama, R; Kumada, T; Kumano, K; Saikawa, I; Shimizu, K; Totsuka, K; Watanabe, Y; Yasuda, T | 1 |
Barry, AL; Jones, RN; Packer, RR | 1 |
Chin, NX; Labthavikul, P; Neu, HC | 1 |
Flux, M; Kramer, J; Laferriere, C; Marks, MI; Stutman, HR | 1 |
Ohtaguro, K; Sakagami, H; Ueda, K; Watanabe, H | 1 |
Arione, R; Bramato, C; Capra, E; Chiavarino, M; Cimino, T; Di Nola, F; Eandi, M; Grosa, M; Salassa, B; Soranzo, ML | 1 |
Daschner, FD; Hoffmann, P | 1 |
Kitaura, K; Minagawa, H; Okachi, R; Sato, K; Yamashita, K | 1 |
Nishino, T; Obana, Y; Tanino, T | 1 |
Braveny, I; Krüger, E; Machka, K | 1 |
Hewitt, WL; Hindler, JA; Kurtz, TO; Martin, WJ; Winston, DJ; Young, LS | 1 |
Cherubin, CE; Corrado, ML; Landesman, SH | 1 |
McCloskey, RV; Trent, JA; Tutlane, VA | 1 |
LeFrock, JL; Miller, MA; Vercler, MJ | 1 |
Weinstein, AJ | 1 |
Braveny, I; Elsser, R; Machka, K | 1 |
Neu, HC; Prince, AS | 1 |
Ernest, KD; Magnussen, CR; Sammartino, MT | 1 |
Agostini, M; Barlocco, G; Bonomi, U; Borgo, G; Bozzino, L; Cabrini, G; Cappelletti, LM; Castellani, L; Conforti, M; Mastella, G | 1 |
Neu, HC | 1 |
Monteil, H; Peladan, F; Zinsius, M | 1 |
Calderwood, SB; Jackson, E; Tung, CC | 1 |
Bergogne-Berezin, E; Joly-Guillou, ML; Verin-Prevost, C | 1 |
Kanno, H; Takahashi, K | 1 |
Miyata, T; Ooto, T; Sei, T; Shima, K; Shima, Y; Takano, N; Uemura, T; Ueno, K; Yonemura, Y | 1 |
Ishibashi, C; Mishina, H; Okuyama, S; Sato, A | 1 |
Horikawa, K; Ishibashi, T; Murakami, K; Ohbuchi, N; Okada, K; Ueda, K | 1 |
Deguchi, K; Fukayama, S; Fukumoto, T; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Tanaka, S; Yokota, N | 1 |
de Boer, E; Johnson, WM; Lior, H; Tilburg, JJ; Woodward, DL | 1 |
Chang, JC; Ho, SW; Hsieh, WC; Hsueh, PR; Luh, KT; Wu, JJ | 1 |
Hanaki, H; Nagayama, A; Nomura, S | 1 |
Fukuhara, J; Furuhata, N; Ikeda, A; Kimura, F; Kouda, M; Maruyama, M; Matsuzaki, H; Nomura, H; Ohgawara, M; Ono, E; Sasaki, K; Satoh, H; Sawabe, E; Suzuki, T; Takahashi, I; Takeuchi, M; Tohi, H | 1 |
Martínek, J; Melenovsky, V; Morávek, J; Spicák, J; Závada, F | 1 |
Ikeda, N; Matsuyama, N; Watanabe, K | 1 |
Nakae, T; Nakajima, A; Saito, K | 1 |
Chen, M; Xu, Y; Zhang, S | 1 |
Chen, MJ; Wang, H | 1 |
Das, BK; Dhawan, B; Kapil, A; Mohanty, S; Singhal, R; Sood, S | 1 |
Hashikita, G; Kawakami, S; Kobayashi, S; Maesaki, S; Nagasawa, M; Okabe, T; Sasaki, K; Shibuya, S; Suzuki, N; Takayama, S; Uchida, T; Watanabe, M; Yamaguchi, T | 1 |
Chang, HT; Chen, IS; Chou, MY; Hsueh, PR; Huang, WK; Hung, MN; Ko, WC; Lee, WS; Lin, CF; Liu, CY; Liu, YC; Luh, KT; Shyr, JM; Teng, LJ; Wang, JH; Wu, JJ | 1 |
Kuo, HY; Lin, ML; Liu, CY; Wang, FD; Yen, YF | 1 |
Emecen, M; Erdem, E; Karaman, S; Kebudi, R; Vural, S; Yildirmak, Y | 1 |
Blahut, L; Hricová, K; Kolár, M; Neiser, J; Urbánek, K; Uvízl, R; Vojtová, V | 1 |
Anjum, R; Fahim, Q; Gill, MM; Hassan, A; Kaleem, F; Khalid, A; Usman, J | 1 |
Afridi, FI; Farooqi, BJ | 1 |
Celebi, S; Demirkaya, M; Hacımustafaoglu, M; Sevinir, B | 1 |
Boral, OB; Cağatay, P; Keçeli, SA; Sonmez, N; Tamer, GS; Willke, A | 1 |
Bosnak, VK; Karaoglan, I; Mete, AO; Namiduru, M; Zer, Y | 1 |
Arda, B; Nazli-Zeka, A; Ozkoren-Calik, S; Pullukcu, H; Sipahi, H; Sipahi, OR; Tasbakan, M; Ulusoy, S; Yamazhan, T | 1 |
Lai, J; Li, S; Liang, L; Peng, B; Wang, Z; Zheng, J | 1 |
Sadikot, RT; Swenson, CE | 1 |
Araya, I; Contreras, S; Fasce, G; Hurtado, V; Núñez, E; Opazo, JL; Quiñones, LA; Saez, E | 1 |
Aynioglu, A; Hacihanefioglu, A; Mutlu, B | 1 |
Ji, JS; Quan, JJ; Wang, HP; Wang, Y; Wang, YF; Xu, YC; Yu, YS | 1 |
Gao, L; Li, Y; Lyu, Y | 1 |
Hao, D; Hu, Z; Liu, X; Sun, T; Tian, H; Wang, T; Wang, X | 1 |
Li, J; Ma, W; Sun, S; Wang, D; Yu, C | 1 |
Chen, Y; Liu, L; Xiang, Q | 1 |
Cao, Y; Liu, C; Ren, H; Shang, Z; Wang, R; Xie, L; Yang, Y; Zhang, J | 1 |
Chang, Q; Ding, L; He, X; Huang, W; Li, X; Wan, X | 1 |
Chen, CH; Chen, CM; Chen, WC; Cheng, WC; Fang, WF; Fu, PK; Ku, SC; Kuo, LK; Lai, CC; Tu, CY; Wang, YT | 1 |
4 review(s) available for cefoperazone and piperacillin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Colonization resistance of the human intestinal microflora: testing the hypothesis in normal volunteers.
Topics: Anti-Bacterial Agents; Antibiosis; Aztreonam; Bacteria, Anaerobic; Cefoperazone; Cefoxitin; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Intestines; Penicillin Resistance; Piperacillin; Yeasts | 1988 |
[Pseudomonas aeruginosa pneumonia].
Topics: Cefoperazone; Cephalosporins; Diagnosis, Differential; Humans; Immunocompromised Host; Penicillins; Piperacillin; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections | 1999 |
Achromobacter respiratory infections.
Topics: Achromobacter; Age Factors; Anti-Bacterial Agents; Bronchiectasis; Cefoperazone; Cephalosporins; Community-Acquired Infections; Comorbidity; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Neoplasms; Penicillins; Piperacillin; Pneumonia, Bacterial; Respiratory Tract Infections; Risk Factors; Sex Factors; Ticarcillin; Virulence Factors | 2015 |
11 trial(s) available for cefoperazone and piperacillin
Article | Year |
---|---|
[In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study].
Topics: Acinetobacter; Cefoperazone; Cefotaxime; Ceftazidime; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterobacteriaceae; Humans; In Vitro Techniques; Mezlocillin; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Ticarcillin | 1991 |
Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Ceftazidime; Costs and Cost Analysis; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Superinfection | 1991 |
Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Bacterial Infections; Cefoperazone; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation; Thienamycins | 1988 |
Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Male; Mezlocillin; Middle Aged; Neutropenia; Piperacillin; Prospective Studies; Random Allocation; Tobramycin | 1988 |
A randomized trial of empirical antibiotic therapy with one of four beta-lactam antibiotics in combination with netilmicin in febrile neutropenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Cefoperazone; Clinical Trials as Topic; Drug Therapy, Combination; Feces; Fever; Gram-Negative Bacteria; Humans; Mezlocillin; Microbial Sensitivity Tests; Netilmicin; Neutropenia; Piperacillin; Random Allocation; Respiratory System; Superinfection; Ticarcillin | 1988 |
Antibiotics in infections of the biliary tract.
Topics: Ampicillin; Bacterial Infections; Cefoperazone; Cholangitis; Cholecystitis; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Prospective Studies; Random Allocation; Tobramycin | 1987 |
Effect of broad-spectrum parenteral antibiotics on "colonization resistance" of intestinal microflora of humans.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria, Anaerobic; beta-Lactamases; Cefoperazone; Cefoxitin; Feces; Gram-Negative Bacteria; Humans; Injections, Intravenous; Penicillin Resistance; Piperacillin | 1987 |
Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
Topics: Adolescent; Alcohol Deterrents; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Cephalosporins; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Eosinophilia; Humans; Moxalactam; Penicillins; Piperacillin; Pseudomonas Infections; Random Allocation; Respiratory Tract Infections | 1983 |
Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Time Factors | 2012 |
Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Sulbactam; Tazobactam | 2013 |
A comparison of the efficacy of piperacillin-tazobactam and cefoperazone-sulbactam therapies in the empirical treatment of patients with febrile neutropenia.
Topics: Adult; Aged; Antineoplastic Agents; Cefoperazone; Drug Combinations; Drug Eruptions; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Leukocyte Count; Male; Middle Aged; Neutrophils; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sulbactam; Treatment Outcome; Young Adult | 2016 |
89 other study(ies) available for cefoperazone and piperacillin
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Biochemical characterization of PER-2 and genetic environment of blaPER-2.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Catalysis; Citrobacter freundii; Conjugation, Genetic; DNA, Bacterial; DNA, Recombinant; Enterobacteriaceae; Genes, Bacterial; Humans; Hydrolysis; Isoelectric Focusing; Kinetics; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Conformation; Protein Sorting Signals; Sequence Analysis, DNA | 2007 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Induction of L1 and L2 beta-lactamases of Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Catechol 2,3-Dioxygenase; Enzyme Induction; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Analysis, DNA; Stenotrophomonas maltophilia | 2008 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; China; Conjugation, Genetic; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Hospitals, University; Humans; Hydrolysis; Intensive Care Units; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Serratia marcescens | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei | 2009 |
Susceptibilities of 23 Desulfovibrio isolates from humans.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Desulfovibrio; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea | 2010 |
In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mutation | 2010 |
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacitracin; Bacterial Proteins; beta-Lactam Resistance; Listeria monocytogenes; Nisin | 2010 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship | 2013 |
[Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefoperazone; Drug Synergism; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Male; Middle Aged; Opportunistic Infections; Piperacillin; Pneumonia; Sepsis; Sulbactam | 1992 |
In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Cefoperazone; Drug Interactions; Drug Therapy, Combination; Gentamicins; Immunoenzyme Techniques; Netilmicin; Piperacillin; Sulbactam; Tobramycin | 1991 |
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of pipera
Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftazidime; Doxycycline; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Fosfomycin; Moxalactam; Piperacillin; Sulbactam | 1990 |
Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillins; Piperacillin; Sulbactam; Ticarcillin | 1990 |
Survey of antibiotic susceptibility among gram-negative bacilli at a cancer hospital.
Topics: Anti-Bacterial Agents; Aztreonam; Cefoperazone; Ceftazidime; Ciprofloxacin; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Piperacillin; Thienamycins | 1988 |
In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Time Factors; Tobramycin | 1986 |
Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.
Topics: Anti-Bacterial Agents; Aztreonam; Cefoperazone; Cefotaxime; Ceftazidime; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa | 1986 |
Comparison of antimicrobial susceptibilities of Pseudomonas aeruginosa isolates, with and without plaques, from two hospitals.
Topics: Amikacin; Carbenicillin; Cefoperazone; Gentamicins; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1986 |
In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Cefoperazone; Ceftazidime; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Mezlocillin; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Ticarcillin | 1986 |
Comparison of the AMS gram-negative susceptibility flex panel GNS-V and agar disk diffusion for testing of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefoperazone; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa | 1987 |
Development of antipseudomonal beta-lactam antibiotics having 2, 3-dioxopiperazine group.
Topics: Animals; Cefoperazone; Chemistry, Pharmaceutical; Dogs; Mice; Piperacillin; Pseudomonas; Rats | 1988 |
[Excretion of antibiotics into bile and urine in patients with external cholecystostomy done in order to treat obstructive jaundice].
Topics: Aged; Aged, 80 and over; Bile; Cefoperazone; Cephamycins; Cholecystostomy; Cholestasis; Female; Humans; Injections, Intravenous; Male; Piperacillin; Time Factors | 1988 |
[Changes in the phagocytic activity of human polymorphonuclear neutrophils induced in vitro by cefotiam vs 6 other antibiotics].
Topics: Adult; Cefoperazone; Cefotaxime; Cefotiam; Ceftazidime; Cephalosporins; Female; Gentamicins; Humans; Luminescent Measurements; Male; Middle Aged; Neutrophils; Phagocytosis; Piperacillin; Rifampin | 1987 |
[Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
Topics: Anti-Bacterial Agents; Azlocillin; Cefoperazone; Ceftazidime; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas; Ticarcillin | 1987 |
Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroidaceae; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Ceftizoxime; Clostridium; Evaluation Studies as Topic; Microbial Sensitivity Tests; Moxalactam; Piperacillin | 1986 |
In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.
Topics: Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Piperacillin; Thienamycins; Tobramycin | 1986 |
Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacteria; Candida; Cefoperazone; Cefoxitin; Enterobacteriaceae; Feces; Female; Humans; Intestines; Male; Piperacillin; Random Allocation | 1987 |
Effect of the topical application of some newer antibiotics on the cerebral cortex.
Topics: Animals; Anti-Bacterial Agents; Bacitracin; Cats; Cefoperazone; Cefotaxime; Cerebral Cortex; Metronidazole; Moxalactam; Piperacillin | 1987 |
Pharmacokinetic studies on the concomitant administration of piperacillin and cefazolin, and piperacillin and cefoperazone in rabbits.
Topics: Animals; Cefazolin; Cefoperazone; Drug Interactions; Infusions, Parenteral; Injections, Intravenous; Kinetics; Male; Piperacillin; Rabbits | 1986 |
BMY28142, cefbuperazone (T-1982), and Sch 34343. Antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteroides; Cefepime; Cefoperazone; Cefoxitin; Cephalosporins; Cephamycins; Chloramphenicol; Clindamycin; Clostridium; Lactams; Metronidazole; Microbial Sensitivity Tests; Piperacillin | 1985 |
The activity of cefbuperazone, a 7 alpha-methoxy 7 beta acyl ureido cephalosporin.
Topics: Bacteria; beta-Lactamases; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Cephamycins; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Piperacillin | 1985 |
Penetration of latamoxef, cefoperazone and piperacillin into the sputum of patients with cystic fibrosis.
Topics: Adolescent; Adult; Cefoperazone; Child; Child, Preschool; Cystic Fibrosis; Humans; Hydrogen-Ion Concentration; Moxalactam; Piperacillin; Pseudomonas aeruginosa; Sputum | 1985 |
[A study on administration of antibiotics during operation for prevention of postoperative infections].
Topics: Adult; Bacterial Infections; Cefoperazone; Child; Cysteine; Humans; Intraoperative Period; Piperacillin; Surgical Wound Infection; Tiopronin | 1985 |
[Cefoperazone: microbiological, kinetic and clinical studies].
Topics: Bacterial Infections; Bronchitis; Cefoperazone; Erysipelas; Humans; Kinetics; Mezlocillin; Piperacillin; Tonsillitis; Urinary Tract Infections | 1985 |
Combination effect of piperacillin with cefoperazone on staphylococci and gram-negative bacteria.
Topics: Bacteria; Cefoperazone; Cephalosporins; Drug Interactions; Microbial Sensitivity Tests; Penicillins; Piperacillin; Staphylococcus | 1982 |
[Bactericidal effects and combined action of micronomicin with beta-lactam antibiotics against Pseudomonas aeruginosa and Escherichia coli].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Synergism; Escherichia coli; Gentamicins; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1983 |
[Antibacterial action of cefoperazone and piperacillin against Escherichia coli].
Topics: Cefoperazone; Cephalosporins; Escherichia coli; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin | 1983 |
[Antibacterial activity of the combination of cefoperazone piperacillin].
Topics: Bacteria; Bacterial Infections; Cefoperazone; Cephalosporins; Drug Combinations; Humans; Penicillins; Piperacillin | 1983 |
Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
Topics: Aminoglycosides; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1980 |
Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1980 |
In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone.
Topics: Aerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Humans; Imipenem; Lactams; Penicillins; Piperacillin; Species Specificity | 1981 |
Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Topics: Azlocillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin; Serratia marcescens | 1981 |
The new cephalosporins and penicillins.
Topics: Azlocillin; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Mezlocillin; Moxalactam; Penicillins; Piperacillin | 1982 |
Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin | 1982 |
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections | 1981 |
Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Humans; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin | 1982 |
Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compounds.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbenicillin; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporinase; Gram-Negative Bacteria; Moxalactam; Penicillinase; Piperacillin | 1983 |
[Comparative activity of azlocillin on Pseudomonas species excluding Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Cephalosporins; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas; Pseudomonas fluorescens | 1984 |
Measurement of levels of aminoglycosides and vancomycin in serum in the presence of new beta-lactam antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Humans; Immunoenzyme Techniques; Mezlocillin; Moxalactam; Penicillins; Piperacillin; Vancomycin | 1984 |
[In vitro comparative activity of 4 beta-lactams against Pseudomonas aeruginosa. Role of cefoperazone].
Topics: Anti-Bacterial Agents; Carbenicillin; Cefoperazone; Ceftazidime; Cephalosporins; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa | 1984 |
Synergistic activities of combinations of beta-lactams, fosfomycin, and tobramycin against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefsulodin; Drug Synergism; Fosfomycin; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 1984 |
[Studies on tissue concentrations of cefoperazone and piperacillin classified by the site of the wall of gallbladder and concentration of piperacillin in the bile after operation].
Topics: Bile; Cefoperazone; Cholecystectomy; Cholelithiasis; Gallbladder; Humans; Piperacillin; Surgical Wound Infection | 1984 |
[Antibiotic and anti-cancer pasting for putrefactive cancers].
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Cefoperazone; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Ointments; Piperacillin; Radiation Injuries; Radiotherapy; Rectal Neoplasms; Sulbactam; Suppuration; Ulcer | 1995 |
[Prevalence of pertussis in Fukuoka: incidence and MICs of antibiotics for Bordetella pertussis isolate].
Topics: Anti-Bacterial Agents; Bordetella pertussis; Cefoperazone; Child; Child, Preschool; Drug Resistance, Microbial; Erythromycin; Humans; Infant; Japan; Piperacillin; Prevalence; Whooping Cough | 1995 |
[beta-lactamase activity in sputum of patients with community-acquired lower respiratory tract infections].
Topics: beta-Lactamases; Cefoperazone; Haemophilus influenzae; Humans; Piperacillin; Respiratory Tract Infections; Sputum; Streptococcus pneumoniae; Sulbactam | 1994 |
A selective medium for the isolation of Arcobacter from meats.
Topics: Animals; Bacterial Typing Techniques; Cattle; Cefoperazone; Culture Media; Cycloheximide; Gram-Negative Bacteria; Meat; Piperacillin; Poultry; Swine; Trimethoprim | 1996 |
Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Colony Count, Microbial; Diffusion; Flavobacterium; Humans; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Piperacillin | 1997 |
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Topics: Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam; Ticarcillin; Urinary Tract; Urinary Tract Infections | 1997 |
[Evaluation of antibacterial activities of various antibiotics against glucose non-fermentative gram-negative rods other than Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Gram-Negative Aerobic Rods and Cocci; Humans; Imipenem; Minocycline; Penicillin Resistance; Penicillins; Piperacillin; Sulbactam; Thienamycins | 1998 |
Penetration of antibiotics into the pancreas in rats: an effect of acute necrotizing pancreatitis.
Topics: Amikacin; Amoxicillin; Animals; Anti-Bacterial Agents; Cefoperazone; Clavulanic Acid; Female; Ofloxacin; Pancreas; Pancreatic Juice; Pancreatitis, Acute Necrotizing; Piperacillin; Rats; Rats, Wistar; Taurocholic Acid; Tissue Distribution | 1999 |
Effect of sulbactam on anti-pseudomonal activity of beta-lactam antibiotics in cells producing various levels of the MexAB-OprM efflux pump and beta-lactamase.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamase Inhibitors; Carrier Proteins; Cefoperazone; Cefsulodin; Drug Synergism; Enzyme Inhibitors; Membrane Transport Proteins; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Sulbactam | 2000 |
[Multicenter evaluation of the antimicrobial activity in vitro for six broad-spectrum beta-lactams in China using the E-test method].
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefepime; Cefoperazone; Ceftazidime; Ceftriaxone; Cephalosporins; China; Imipenem; Microbial Sensitivity Tests; Piperacillin | 2000 |
[Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Sulbactam | 2003 |
Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acids; Cross Infection; Gram-Negative Bacteria; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Ticarcillin | 2005 |
[The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Oxazines; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Thienamycins | 2006 |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data.
Topics: Bacteria; Cefoperazone; Drug Combinations; Humans; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam | 2007 |
In vitro activities of piperacillin or cefoperazone alone and in combination with beta-lactamase inhibitors against gram-negative bacilli.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cefoperazone; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam | 2009 |
Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units.
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Czech Republic; Drug Resistance, Multiple, Bacterial; Gentamicins; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam | 2011 |
Frequency and antibiogram of multi-drug resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cefoperazone; Colistin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam | 2011 |
Activity of beta-lactam beta-lactamase inhibitor combinations against extended spectrum Beta-lactamase producing Enterobacteriaceae in urinary isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acids; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sensitivity and Specificity; Sulbactam; Urinary Tract Infections | 2012 |
Interaction between caspofungin or voriconazole and cefoperazone-sulbactam or piperacillin-tazobactam by in vitro and in vivo methods.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Candida albicans; Candidiasis; Caspofungin; Cefoperazone; Drug Interactions; Echinocandins; Female; Lipopeptides; Mice; Mice, Inbred BALB C; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyrimidines; Sulbactam; Triazoles; Voriconazole | 2014 |
In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Tigecycline | 2013 |
Piperacillin/tazobactam vs. cefoperazone/sulbactam in adult low-risk febrile neutropenia cases.
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Combinations; Febrile Neutropenia; Female; Humans; Male; Middle Aged; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Sulbactam; Treatment Outcome | 2014 |
[Experimental study on concentrations and pharmacokinetics of antibiotics in bile and evaluation of their microbicidal potential].
Topics: Animals; Anti-Bacterial Agents; Bile; Cefoperazone; Drug Combinations; Meropenem; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rabbits; Random Allocation; Sulbactam; Thienamycins | 2014 |
A Non-inferiority Pilot Study Comparing the Clinical Efficacy and Safety of Generic Wide-spectrum Antibiotic Use in Septic Oncology Patients.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drugs, Generic; Female; Humans; Imipenem; Male; Middle Aged; Oncology Service, Hospital; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Sepsis; Sulbactam; Treatment Outcome | 2015 |
[The activity of moxalactam against Enterobacteriaceae and anaerobia in vitro].
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Cefoperazone; Enterobacteriaceae; Escherichia coli; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Moxalactam; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus; Thienamycins | 2016 |
Trends in Drug Resistance of
Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; China; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2017 |
[Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015]
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Cross Infection; Drug Resistance; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Retrospective Studies; Thienamycins | 2016 |
In vitro interaction of various antibiotic combinations recommended by Chinese consensus statement against carbapenems-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefoperazone; Ceftazidime; China; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2019 |
Comparison of antibiotic-associated diarrhea caused by cefoperazone/sulbactam or piperacillin/tazobactam in neurosurgery patients.
Topics: Anti-Bacterial Agents; Cefoperazone; Diarrhea; Humans; Microbial Sensitivity Tests; Neurosurgery; Penicillanic Acid; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam | 2021 |
Characteristics of and antibiotic resistance in urinary tract pathogens isolated from patients with upper urinary tract stones.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefoperazone; Drug Resistance, Bacterial; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Male; Microbial Sensitivity Tests; Piperacillin; Sulbactam; Tazobactam; Urinary Calculi; Urinary Tract; Urinary Tract Infections | 2023 |
Cross-reactivity between piperacillin-tazobactam and cefoperazone-sulbactam in drug-induced immune thrombocytopenia.
Topics: Aged; Anti-Bacterial Agents; Cefoperazone; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Purpura, Thrombocytopenic, Idiopathic; Sulbactam | 2023 |
The clinical efficacy of cefoperazone-sulbactam versus piperacillin-tazobactam in the treatment of severe community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Cefoperazone; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; Sulbactam; Treatment Outcome | 2023 |